BioMarin Pharmaceutical Market Sentiment

BioMarin Pharmaceutical Inc

BMRNNASDAQ

Trade with Public

$58.51

1.021.77%

마지막 업데이트: Oct 30, 5:25 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 주식 보고서

실적: Q3 2026 실적이 내일 월 11월 2nd에 시장 마감 후 발표됩니다.

컨퍼런스 콜: 내일 4:30 오후에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

BioMarin Pharmaceutical Market Sentiment

Market sentiment signals for BioMarin Pharmaceutical (BMRN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 6.3% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

34 analysts

Options Flow (P/C)

—

Avg Consensus PT

$89

+51.6%

Highest Price Target

$126

+115.2%

Piper Sandler

Lowest Price Target

$60

+2.5%

HC Wainwright & Co.

Short Interest

6.3%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	Morgan Stanley	Matthew Harrison—	+108.3%	$124 → $122	Maintained	Overweight
Oct 20, 2026	JP Morgan	Jessica Fye—	+48.6%	$86 → $87	Maintained	Overweight
Oct 20, 2026	Cantor Fitzgerald	Olivia Brayer Saunders—	+46.9%	$86 → $86	Maintained	Overweight
Oct 15, 2026	UBS	Joon Lee—	+50.3%	$114 → $88	Assumes	Buy
Oct 14, 2026	Barclays	Eliana Merle—	+94.7%	$111 → $114	Maintained	Overweight
Sep 10, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+2.5%	$60 → $60	Maintained	Neutral
Sep 1, 2026	Piper Sandler	Allison Bratzel—	+53.7%	$88 → $90	Maintained	Overweight
Aug 31, 2026	Jefferies	Akash Tewari—	+79.3%	$104 → $105	Maintained	Buy
Aug 31, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+2.5%	$59 → $60	Maintained	Neutral
Aug 19, 2026	BMO Capital	David Lebowitz—	+67.4%	$98	Initiate	Outperform
Aug 18, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+0.8%	$60 → $59	Maintained	Neutral
Aug 17, 2026	Piper Sandler	Allison Bratzel—	+50.3%	$82 → $88	Maintained	Overweight
Aug 17, 2026	Barclays	Eliana Merle—	+89.6%	$105 → $111	Maintained	Overweight
Aug 10, 2026	Canaccord Genuity	Whitney Ijem—	+94.7%	$111 → $114	Maintained	Buy
Aug 7, 2026	Morgan Stanley	Matthew Harrison—	+111.8%	$119 → $124	Maintained	Overweight
Aug 7, 2026	Oppenheimer	Leland Gershell—	+65.7%	$95 → $97	Maintained	Outperform
Aug 7, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+2.5%	$50 → $60	Maintained	Neutral
Jul 16, 2026	Citigroup	Eric Joseph—	+29.8%	$75 → $76	Maintained	Buy
Jul 7, 2026	RBC Capital	Luca Issi—	+5.9%	$66 → $62	Maintained	Sector Perform
May 22, 2026	Canaccord Genuity	Whitney Ijem—	+89.6%	$116 → $111	Maintained	Buy
May 19, 2026	B of A Securities	Jason Zemansky—	+36.6%	$85 → $80	Maintained	Buy
May 19, 2026	Citigroup	Eric Joseph—	+28.1%	$75	Initiate	Buy
May 18, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-14.6%	$55 → $50	Maintained	Neutral
May 11, 2026	Goldman Sachs	Salveen Richter—	+17.8%	$69	Reinstates	Buy→Neutral
May 7, 2026	Canaccord Genuity	Whitney Ijem—	+98.1%	$104 → $116	Maintained	Buy